SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-13-182137
Filing Date
2013-04-29
Accepted
2013-04-29 16:26:00
Documents
5
Period of Report
2013-06-19
Effectiveness Date
2013-04-29

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d526337ddef14a.htm DEF 14A 373675
2 GRAPHIC g526337g67t62.jpg GRAPHIC 6095
3 GRAPHIC g526337g73w25.jpg GRAPHIC 17126
4 GRAPHIC g526337pc_001c.jpg GRAPHIC 3983
5 GRAPHIC g526337pc_001d.jpg GRAPHIC 9711
  Complete submission text file 0001193125-13-182137.txt   426168
Mailing Address 260 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080
Business Address 260 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080 650.243.3100
KALOBIOS PHARMACEUTICALS INC (Filer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35798 | Film No.: 13791970
SIC: 2834 Pharmaceutical Preparations